SCHEMBL21579271

SCHEMBL21579271

c1ccc(-c2ccc(-c3c4ccccc4c(-c4ccc5oc6c(-c7cccc(-c8cccc(-c9c%10ccccc%10c(-c%10ccc%11oc%12ccccc%12c%11c%10)c%10ccccc9%10)c8)c7)cccc6c5c4)c4ccccc34)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.54
GGPS1 O95749 1/20 0.44
PLA2G2A P14555 4/20 0.43
PLA2G4A P47712 4/20 0.43
PLA2G10 O15496 1/20 0.43
PRKDC P78527 5/20 0.41
PTGES2 Q9H7Z7 1/20 0.41
NPC1 O15118 2/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PIM1 P11309 1/20 0.38
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
PIM3 Q86V86 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL126532 0.99 ALOX5 (0.56) ALOX5GGPS1PLA2G2APLA2G4APLA2G10
SCHEMBL19770500 0.96 ALOX5 (0.51) ALOX5GGPS1PLA2G2APLA2G4APLA2G10
SCHEMBL24564515 0.96 ALOX5 (0.58) ALOX5GGPS1PLA2G2APLA2G4APLA2G10
SCHEMBL126822 0.96 ALOX5 (0.58) ALOX5GGPS1PLA2G2APLA2G4APLA2G10
SCHEMBL126817 0.95 ALOX5 (0.53) ALOX5GGPS1PLA2G2APLA2G4APLA2G10
SCHEMBL12577966 0.94 ALOX5 (0.56) ALOX5GGPS1PLA2G2APLA2G4APLA2G10
SCHEMBL23057014 0.94 ALOX5 (0.56) ALOX5GGPS1PLA2G2APLA2G4APLA2G10
SCHEMBL23083113 0.94 ALOX5 (0.56) ALOX5GGPS1PLA2G2APLA2G4APLA2G10
SCHEMBL10443091 0.94 ALOX5 (0.56) ALOX5GGPS1PLA2G2APLA2G4APLA2G10
SCHEMBL10442960 0.94 ALOX5 (0.56) ALOX5GGPS1PLA2G2APLA2G4APLA2G10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10680181-B2 Organic electroluminescence device and novel compound IDEMITSU KOSAN CO., LTD. (JP) 2020-06-09 US disclosed
US-20190355914-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2019-11-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10680181-B2 Organic electroluminescence device and novel compound PIEZO1, TMEM109, OXA1L ALOX5 4031/4885GGPS1 1881/4885PLA2G2A 4620/4885
US-20190355914-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND PIEZO1, TMEM109, OXA1L ALOX5 4031/4885GGPS1 1881/4885PLA2G2A 4620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.